Capricor Therapeutics Stock Price on December 19, 2024
| CAPR Stock | USD 14.08 0.07 0.50% |
Below is the normalized historical share price chart for Capricor Therapeutics extending back to June 20, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Capricor Therapeutics stands at 14.08, as last reported on the 26th of December, with the highest price reaching 14.30 and the lowest price hitting 13.61 during the day.
If you're considering investing in Capricor Stock, it is important to understand the factors that can impact its price. Capricor Therapeutics appears to be slightly risky, given 3 months investment horizon. Capricor Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0986, which signifies that the company had a 0.0986% return per unit of risk over the last 3 months. By analyzing Capricor Therapeutics' technical indicators, you can evaluate if the expected return of 0.97% is justified by implied risk. Please makes use of Capricor Therapeutics' Downside Deviation of 7.28, risk adjusted performance of 0.1378, and Mean Deviation of 6.78 to double-check if our risk estimates are consistent with your expectations.
At this time, Capricor Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 12/26/2024, Common Stock Shares Outstanding is likely to grow to about 28.1 M, while Common Stock is likely to drop slightly above 20.7 K. . At this time, Capricor Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 12/26/2024, Price Earnings To Growth Ratio is likely to grow to 0.21, while Price Earnings Ratio is likely to drop (6.17). Capricor Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of February 2007 | 200 Day MA 9.0906 | 50 Day MA 17.725 | Beta 4.016 |
Capricor |
Sharpe Ratio = 0.0986
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CAPR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.82 actual daily | 87 87% of assets are less volatile |
Expected Return
| 0.97 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Capricor Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Capricor Therapeutics by adding it to a well-diversified portfolio.
Price Book 9.3318 | Enterprise Value Ebitda (2.73) | Price Sales 27.4252 | Shares Float 25.7 M | Wall Street Target Price 41.2857 |
Related Headline
Bio Path Headline on 19th of December 2024
Bio-Path Holdings Announces Preclinical Testing of BP1001-A ... by finance.yahoo.com
Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 DiabetesHOUSTON, Dec. 19, 2024 -- Bio-Path Holdings, Inc., , a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today reported that results from preclinical studies of BP1001-A for obesity demonstrated enhanced insulin sensitivity, confirming BP1
Capricor Therapeutics Valuation on December 19, 2024
It is possible to determine the worth of Capricor Therapeutics on a given historical date. On December 19, 2024 Capricor was worth 12.69 at the beginning of the trading date compared to the closed value of 12.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Capricor Therapeutics stock. Still, in general, we apply an absolute valuation method to find Capricor Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Capricor Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Capricor Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 13.13 | 13.66 | 12.25 | 12.52 | 1,154,875 | |
12/19/2024 | 12.69 | 13.06 | 12.30 | 12.90 | 1,146,502 |
| 12.64 | 13.53 | 12.57 | 13.07 | 5,853,113 |
| Backtest Capricor Therapeutics | | | Capricor Therapeutics History | | | Capricor Therapeutics Valuation | Previous | Next |
Capricor Therapeutics Trading Date Momentum on December 19, 2024
| On December 20 2024 Capricor Therapeutics was traded for 13.07 at the closing time. The top price for the day was 13.53 and the lowest listed price was 12.57 . The trading volume for the day was 5.9 M. The trading history from December 20, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 1.32% . The overall trading delta against the current closing price is 8.60% . |
Capricor Therapeutics Fundamentals Correlations and Trends
By evaluating Capricor Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Capricor Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Capricor financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Capricor Therapeutics Stock history
Capricor Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Capricor is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Capricor Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Capricor Therapeutics stock prices may prove useful in developing a viable investing in Capricor Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.8 M | 28.1 M | |
| Net Loss | -26.1 M | -24.8 M |
Capricor Therapeutics Stock Technical Analysis
Capricor Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Capricor Therapeutics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Capricor Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Capricor Therapeutics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Capricor Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Capricor Therapeutics shares will generate the highest return on investment. By undertsting and applying Capricor Therapeutics stock market strength indicators, traders can identify Capricor Therapeutics entry and exit signals to maximize returns
Capricor Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Capricor Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Capricor Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Capricor to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1378 | |||
| Jensen Alpha | 1.86 | |||
| Total Risk Alpha | 1.36 | |||
| Sortino Ratio | 0.2515 | |||
| Treynor Ratio | 42.3 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.